Weight-loss drugs like Ozempic are in such huge demand that spending on them will hit $100 billion by 2035, analyst says

The global market for novel weight-loss drugs like Novo Nordisk A/S’s Ozempic and Wegovy is poised to reach $100 billion by 2035 as patients start to understand the efficacy of the medications. That’s according to BMO Capital Markets analyst Evan David Seigerman, who, in a note to clients late…#bmocapitalmarkets #evandavidseigerman #novonordiskswegovy #elilillyco #lilly

Source: Reuters: Health - September 22, 2023 Category: Consumer Health News Source Type: news